Stock Chart

RVMD

$97.16 +0.22%
Score: 56.0 HOLD
LEAPs: SELL $120
i
LEAPs Option Signal

Type: SELL wallstreet
Strike: $120
Premium: $12.30
Expiry: Jan 15, 2027
Target: $116
Score: -100

LEAPs are long-term options (1+ year) with less time decay.
30D Target: $67.59 - $111.36 STRONG_UPTREND
i
30D Trendline Target

This is a PROJECTED price range based on extrapolating the current trendline slope forward 30 days.

How it works:
• Draws support and resistance trendlines
• Calculates slope (rate of change)
• Projects lines to 30 days future

Signals:
● STRONG_UPTREND: Steep rise
● UPTREND: Moderate rise
● SIDEWAYS: Flat/Mixed
● DOWNTREND: Falling

⚠️ Not a prediction. Shows trend projection only.

R-squared: 0.87
Vol: 0.46x (vs SPY: 0.5x | vs QQQ: 0.5x)
Volume Ratio Explained

Vol: Current volume vs 20-day average
vs SPY: Relative activity vs market
vs QQQ: Relative activity vs tech

Color Guide:
● Red (≥1.5x): High activity
● Yellow (≥1.2x): Above average
● Blue (≤0.7x): Low activity

Interpretation:
• vs SPY > 1: Stock-specific interest
• vs SPY < 1: Stock quiet vs market
Technical Chart
CHART OVERLAYS
Active: 2
INDICATORS
TRENDLINES
OPTIONS FLOW
VOLUME & PRICE
OTHER

About RVMD - Revolution Medicines, Inc. Common Stock

Revolution Medicines Inc is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS and mTOR signaling pathways. The company's products includes RMC-4630, a SHP2 inhibitor, RAS(ON) portfolio and SOS1 and 4EBP1/mTORC1 programs.

Key Statistics

Market Cap $19B

This RVMD stock chart provides comprehensive technical analysis including candlestick patterns, volume profile analysis, and options open interest data. Track RVMD's price movements with trendlines, gamma walls, and key support/resistance levels.